These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 789045

  • 21. In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.
    Levison ME, Knight R, Kaye D.
    Antimicrob Agents Chemother; 1972 May; 1(5):381-4. PubMed ID: 4670478
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A, Montini G, Ramacciotti PG.
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M.
    Med Klin; 1978 Jun 16; 73(24):914-7. PubMed ID: 661734
    [Abstract] [Full Text] [Related]

  • 29. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM, Mackay E, Marks MI.
    Chemotherapy; 1975 Jun 16; 21(2):90-8. PubMed ID: 168040
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative in vitro activity of tobramycin and gentamicin on three different media.
    Sandven P, Lassen J, Solberg O, Evandt O.
    Chemotherapy; 1980 Jun 16; 26(5):354-60. PubMed ID: 7389429
    [Abstract] [Full Text] [Related]

  • 32. [Tobramycin--clinical pharmacology and chemotherapy].
    Periti P.
    J Chemother; 1996 Jan 16; 8 Suppl 1():3-30. PubMed ID: 8948764
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT, Andriole VT.
    Yale J Biol Med; 1980 Jan 16; 53(2):149-59. PubMed ID: 6446810
    [Abstract] [Full Text] [Related]

  • 36. In vitro studies of tobramycin.
    Bodey GP, Stewart D.
    Antimicrob Agents Chemother; 1972 Sep 16; 2(3):109-13. PubMed ID: 4790551
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB, Penner JL.
    Can Med Assoc J; 1975 Jul 12; 113(1):29-31. PubMed ID: 807310
    [Abstract] [Full Text] [Related]

  • 39. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D, Moreno-López M, Martínez-Beltrán J, García-Iglesias MC.
    J Infect Dis; 1976 Nov 12; 134 SUPPL():S394-90. PubMed ID: 825591
    [Abstract] [Full Text] [Related]

  • 40. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL, Smith RP, Ritz W.
    Chemotherapy; 1994 Nov 12; 40(6):391-8. PubMed ID: 7842822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.